News & Events

NEWS

February 25, 2025

BioCentury Article | Emerging Company Profile

Lifordi: Applying ADCs to Autoimmune Conditions

January 9, 2025

Lifordi Immunotherapeutics Appoints Matthew W. McClure, M.D., as Chief Medical Officer

September 27, 2024

Lifordi Named Winner of Endpoints 11 as Developer of Antibody Drug Conjugates for Autoimmune and Inflammatory Diseases

To watch the Endpoints 11 award ceremony, register here. Lifordi’s acceptance is at the ~16:30 mark.

EVENTS

September 18, 2024, 1:00pm
Stifel 2024 Virtual Immunology and Inflammation Summit